chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore throat within hour for receiving vaccine, head ache, coughing congestion, bronchitis symptoms a few days later.
No longer tired and her hair has grown back; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (No longer tired and her hair has grown back) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (COVID made her tired and her hair started to fall out.).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (No longer tired and her hair has grown back). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (No longer tired and her hair has grown back) outcome was unknown.            No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable.
Approximately 5-10 minutes after receiving the Menactra vaccine, she became light headed. The mother helped her to lay down. Mother noticed some twitching which lasted 10 seconds. P 40 BPM and regular BP 120/60. BP remained normal and pulse increased over the next 10 minutes. Drank some water, felt better and went home accompanied by her mother. Sent for EKG, EEG, CMP, Neuro and Cardio consult.
Patient complained of numbness and pain at injection site.  These symptoms began within hours of receiving vaccine.  The pain was described as "immense pressure, injection area tightness and a burning sensation".  Over the course of the following weeks until death patient suffered from numbness that traveled from injection site through left side of body and became fixed.  Chronic fatigue, Loss of balance, Left side hearing loss,  Double vision/blindness, Dementia, Rigid Limbs,  Graphic Tremors in limbs and chest,  Lost ability to communicate due to muscle rigidity and loss of muscle control, loss of mobility, Suffered from delusions and hallucinations.  Acute degrade of cognition until Death.
Pt vaccinated with DTP/OPV developed fever to 102 for one day; Five days after immunization, developed erythema multiforme rash. No mucous membrane involvement.
Moderna COVID-19 Vaccine EUA.  Red spot at injection site, measuring approximately 2" in diameter appeared on Mar 17.   Also at 8:15am on Mar 17 I had a seizure.   I had second seizure while lying on the couch at 5:15pm Mar 17.   No other assignable cause.  Mar18-20 I was often light-headed but no additional seizures.
Fiery red rash LUA peri-injection site at time of report rash resolving
I had a headache and body aches the first night. After a couple weeks I was still very tired and wasn't bouncing back. The did a remote device check on pacemaker and they called me and told me that I was in AFIB since the middle of December. They were monitoring me every week hoping it would regulate, but it didn't. I went to the doctor. I was scheduled for an oblation 03/31/22 and got that done. About 10 days later, HCF to have my pacemaker checked and everything was fine. A week later, my daughter came to my house, and I was unconscious. She called the EMT, and they took me to the HCF and was scheduled for a Cardio Conversion. They did that and it went back into rhythm. That is when they increased my COREG dosage and took me off losartan. I am doing better now but have small bouts of AFIB still.
Diarrhea up to 11 times 3 days after vaccination yesterday 10/17/07.  Diarrhea x 6.  Vomiting.
Patient received vaccination on 9/26 and experienced no reactions until 11/8.  On this day, patient experienced muscle ache and swelling in injection arm, edema surrounding elbow and lower portion of upper arm, and a fever (confirmed COVID negative). Patient's symptoms resolved slowly over the course of 9 days.
gallbladder problems /gallbladder completely destroyed; gallbladder problems/crawling on the floor with pain; have no energy; bloated; My quality of life is greatly diminished; This is a spontaneous report from an Agency from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported. 3 months after taking vaccine, patient was crawling on the floor with pain and gallbladder completely destroyed. Now patient had no energy and was bloated continually. Patient's quality of life was greatly diminished to top it off. Outcome of no energy and bloated was not resolved. Outcome of other events was unknown.  The lot number for the vaccine BNT162B2, was not provided and will be requested during follow-up.
Information has bee received from a physician referring to a patient of unknown age and gender. On an unknown date the patient was vaccinated with the second dose of GARDASIL (dose, lot # and route were not reported) 2 months after the first dose and then was vaccinated with the third dose of GARDASIL 2 months after the second dose (inappropriate schedule of vaccine administered). No adverse effect was reported. Additional information has been requested.
15 year old female found in supine position with feet elevated in vaccination area.  Pt had a left upper lip injury (non-bleeding) , redness and slight swelling to left lateral eye area.  She also had a less than dime sized abrasion to right knee.  Pt was recovered from dizziness (syncope)  and then placed into a wheelchair and placed onto a cot in the observation area with her feet elevated with a chair.  VS 107/73 66 24 and an O2 sat of 99% on RA   Pt timid and somewhat afraid of passing out again.  Chair was later removed and then pt sat up in bed with apprehension.  She ate a bag of doritos and drank a half bottle of water ( about 250 ml)  She then stood up and denied any dizziness but insisted on sitting and/or lying down.  She did sit back down for another 10 minutes and later stood up , denies any symptoms.  Pt then ambulated to BR without help, MAEW, NAD, steady gait.  She was a + o x 3,  VS at 1431  111/69 74 22 with O2 sat of 99% on RA.  Pt and mother given directions to change positions slowly allowing 30-60 seconds per position change.  They both acknowledged this.  Pt discharged home with sister and mother with direction to f/u with pcp as needed and to increase sodium and water intake today and tomorrow.     No medical history Denies taking any medications Denies any allergies   (name), site supervisor aware of situation.    Vaccination Site
Incorrect Immunization dosage was given to patient out of age range. No medical/clinical reaction was experienced.
Anaphylactic reaction starting with flushed face, red eyes, eye swelling proceeding to skin rash, rapid heart rate, trouble breathing. Went to ER and was administered steroids and antihistamine and prescribed same. Reaction continued and had to take 2nd course of steroids.
Fever that lasted 36 hours, peaked at 100.9; Chills; Extreme fatigue; Injection site pain; Injection site pain, redness; Injection site pain, redness & swelling; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: FF2588Wag5760) via an unspecified route of administration in the left arm on 30Aug2021(at the age of 46-years-old) as a single dose for COVID-19 immunisation. The medical history included hypothyroidism. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing.  On 31Aug2021, the patient experienced fever that lasted 36 hours, peaked at 100.9, chills, extreme fatigue, injection site pain, redness and swelling. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the event fever was recovered on an unknown date in Sep2021, while that of chills, extreme fatigue, injection site pain, redness and swelling was recovering at the time of this report.
Pt received Moderna #1 8/10/21 followed by Pfizer #1 9/10/21
Began feeling chilled around 8 PM.  Put on additional clothing. Nominal headache around 9 PM. Still feeling chilled. Retired to bed at 10 PM, using a heated mattress pad.  Began to noticeably shiver about 11 PM. Shook until past 2 AM.  Very little sleep.  Began to feel overheated around 4 AM.  Arose about 8 AM, no longer hot, but feeling tired, probably from lack of good sleep.  Chills/fever symptoms were gone and I felt better.
Small red spot appeared at first, the following day the area had become larger and pronounced, with hard swelling below the skin and a deeper red coloring, the next day the swelling went down substantially and the redness had spread into a larger area on the left arm, but was a lighter red,
SORE ARM; HEADACHE; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced sore arm, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore arm and headache was not reported. This report was non-serious.
Stroke from blood clot. .Surgical thrombectomy .  After initial full paralysis on left side, not adverse effects.
Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Headache-Medium
had flu like symptoms over Christmas; inflamed area slowly got smaller; nerve pain in joints / nerve pain in joints throughout his body; pain; his arm swelled from elbow to shoulder; arm was red; hot to the touch; arm was also very sore; This case was reported by a consumer via interactive digital media and described the occurrence of influenza-like symptoms in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included fluticasone propionate (Fluticasone Diskus) inhalation powder for asthma and salmeterol xinafoate (Salmeterol Diskus) for asthma and reactive airways disease.   The patient's past medical history included knee pain. Previously administered products included Shingrix with an associated reaction of influenza like illness (received 1st dose in September 2019, refer case US2020AMR022243) and Advair Diskus 500/50 with an associated reaction of bronchial hyperreactivity (received puff twice daily and started in 2000). Concurrent medical conditions included asthma and reactive airways disease. Concomitant products included glucosamine and ipratropium bromide + salbutamol sulfate (Combivent).   On 21st December 2019, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, the patient started Fluticasone Diskus 1 puff(s) once daily (1 puff(s) daily) and Salmeterol Diskus 1 puff(s) once daily (1 puff(s) daily). On an unknown date, less than 2 weeks after receiving Shingrix, less than a year after starting Fluticasone Diskus and an unknown time after starting glucosamine, the patient experienced influenza-like symptoms, swelling arm, erythema of extremities, feeling hot, pain in arm, inflammation, nerve pain and joint pain. The patient was treated with codeine phosphate + paracetamol (Tylenol #4). Rechallenge with Shingrix was positive. On an unknown date, the outcome of the influenza-like symptoms, nerve pain and joint pain were unknown and the outcome of the swelling arm, erythema of extremities, feeling hot, pain in arm and inflammation were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, swelling arm, erythema of extremities, feeling hot, pain in arm, inflammation, nerve pain and joint pain to be related to Shingrix and Fluticasone Diskus.  Additional details were received as follows: The patient after vaccination had arm swelling from elbow to shoulder, and was red and hot to the touch. The patient arm was sore. The patient also had nerve pain in joints throughout his body. The patient past medical history include damage to his lungs, bulging discs. The patient shoulder blades and elbows were the worst, but he also gets joint pain in his ankles, knees, hips and wrists. The patient felt like when the dentist gets too close to the nerve of a tooth. In addition to the local symptoms and joint pain, he also had flu like symptoms.
area of redness about 6 inches vertical and 3 inches horizontal around the injection site.  It is not itching and does not appear to have any fluid or blistering. it does blanch.  advised mom may apply warm compresses and give benadryl as directed, some redness as vaccine site not uncomon.
Information has been received from a dental hygenist concerning her approximately 2 year old son who was vaccinated with the fourth dose of hepatitis B virus vaccine. Secondary suspect vaccinations included a dose of MMR. Other concomitant vaccinations included all of the others. The patient's mother reported that her son was subsequently diagnosed as being autistic around his second birthday. The patient's mother also reported that her son may have received the fourth dose of hepatitis B virus vaccine in error. Unspecified medical attention was sought and at the time of this report the outcome was unknown. The patient's mother felt that her child's condition was a result of the cumulative effects of thimerosal that her son had received as a child. At the time of this report, the patient was 5 years old. Upon internal review, autism was considered to be an other important medical event (OMIC). No further information is available.
Site: Pain at Injection Site-Severe, Additional Details: severe arm pain radiating to neck and down arm.  limited arm mobility, still having pain at injection site and wakes her up at night
slightly swollen arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 24Mar2021 14:00 (Batch/Lot number: unknown) at the age of 43 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset 2021, outcome "unknown", described as "slightly swollen arm". Additional information: The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient has no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
HYPOXIA 6/27/2022 &  10/6/2022  --  RECURRENCE OF SAME SYMPTOMS
As I was in and out of sleep with a high fever I woke up to a loud buzzing in my ears, eyes flickering/blinking uncontrollably, locked jaw, body convulsing for about 5 seconds then pulled out of it.  Never had anything like that happen before.   Wanted to yell for help but was unable to form words during the episode.  After it happened I have terrible sweats but felt stable enough to not wake anyone up. Spent the next day resting with no energy.
severe headache; chills/chills are getting worse; This is a spontaneous report received from contactable reporter (Consumer or other non-HCP) from medical information team. The reporter is patient's husband.  An 89-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm, administration date 10Jan2022 10:00 (Lot number: FE3594) at the age of 89 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Multiple myeloma", start date: 2020 (unspecified if ongoing), notes: Caller says this was diagnosed about two years ago.; "Lung cancer", start date: 2010 (unspecified if ongoing), notes: Caller says this was diagnosed 12 years ago.; "hard of hearing" (ongoing). There were no concomitant medications. The following information was reported: HEADACHE (non-serious) with onset 10Jan2022 11:00, outcome "not recovered", described as "severe headache"; CHILLS (non-serious) with onset 10Jan2022, outcome "not recovered", described as "chills/chills are getting worse". Therapeutic measures were taken as a result of headache, chills included paracetamol (TYLENOL).   No follow-up attempts are possible. No further information is expected.
Lightheaded then passed out, woke up with chest pain, gradually very low pressure and seizure
TINNITUS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced tinnitus. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of tinnitus was not reported. This report was non-serious. This case, from the same reporter is linked to 20220105609.
Information has been received from a field employee and a nurse concerning a two patients who were vaccinated with a dose of VARIVAX (Merck) (date, dose route and lot number not reported). The field employee stated that the nurse discovered that two patients who were given at least one dose of VARIVAX (Merck) had a chicken pox outbreak. The nurse clarified that the two patients involved were administered two doses of VARIVAX (Merck) and were subsequently diagnosed with herpes zoster (date unspecified). Both patients' zoster had a distribution of the right neck. At the time of the report the outcome of the patients were unknown. It was unspecified if the patients sought medical attention. Follow-up information has been received from the registered nurse who reported that many years ago she was doing auditing and she saw that one boy came in to the nurses' office. It was reported that there was on boy that was unrelated, not in the same classes or lunch, with different physicians. The boy on unspecified dates, had received two doses of VARIVAX (Merck) and had the same mild chicken pox outbreak on neck. The registered nurse contacted during telephone follow-up could not supply the following information: patient 's name, dates of birth, dates of vaccination, lot numbers, dates of the events, recovery status, health care provider name and contact information. This is a consolidation of two reports concerning the same patients. This is one of several reports received from the same source. Additional information is not expected.
CRVO right eye.  Onset one day post Vaccine  Spoke with pt. on December 1, 2022.  On November 17, 2022 he developed a change in vision while traveling.  It progressed, so he was seen on November 21st by Dr.  They suspected a central retinal vein occlusion (CRVO).  His sx's progressed over the weekend so he saw a retinal specialist the next day.  It continued to get worse so he saw Dr again on November 29th and was given an injection.  He has also been on a course of steroids.  Unfortunately his vision has not cleared yet and there is still evidence of inflammation in his retina.  This is typically a condition that occurs in older patients with other risk factors.   Pt. is young and does not have any of the usual risks associated with this condition.  On the day prior to his symptoms he received his annual influenza vaccine as required by his employment.  Reviewing the medical literature, there are case reports of CRVO occurring after administration of vaccines, including the influenza vaccine. At his young age with no risk factors, it is likely that this occurred as a complication of recent vaccination.
This case was reported by a nurse via sales rep and described the occurrence of injected limb mobility decreased in a 47-year-old female patient who received FLUARIX QUADRIVALENT (batch number NJ4PP, expiry date 23rd June 2016). Concomitant products included CYMBALTA, SUDAFED, vitamin D nos, XANAX and ZANTAC. On 4th September 2015, the patient received FLUARIX QUADRIVALENT (intramuscular). On 9th September 2015, 5 days after receiving FLUARIX QUADRIVALENT, the patient experienced injected limb mobility decreased and shoulder pain. The patient was treated with MOTRIN. On an unknown date, the outcome of the injected limb mobility decreased was unknown and the outcome of the shoulder pain was unchanged. It was unknown if the reporter considered the injected limb mobility decreased and shoulder pain to be related to FLUARIX QUADRIVALENT. Additional details were received as follows: The patient received a dose of FLUARIX QIV in the left deltoid. On 9th September 2015, the patient experienced left shoulder pain and decreased range of motion of the shoulder. The patient was treated with MOTRIN (800mg) to help her move and for the pain.
Area around injection side became red, somewhat swollen, hot to touch and rash that itched. Affected area became larger as the day progressed. It began as rather circular but eventually covered an area about 7 inches long and 3 inches wide. I iced it and put cortisone cream on it several times. It was slightly red after 2 1/2 days but no longer itched after about 2 days.  Perhaps unrelated, but about 36 hours from onset of rash, I had mild chills and  back pain. Both disappeared by the next morning. Saw online this is being called ?COVID arm?.
What others describe as ?covid arm?.   Red blotchy rash around injection site that appeared today (7 days later). So no itching or pain, just red and warm to touch.
Phone call from pt stating that she experienced tingling in right arm (almost immediately) after rabies vaccine. Within minutes the entire arm from shoulder to finger tips tingled and "burned like fire". She stated this lasted 20 minutes. States area was swollen until 5 days later, the area only looked like a mosquito bite and the pt denies problems now except for itching at the site. Phone call to the pt, she states she has had no further problems. She says that she has decided not to take any more in the future.
WARM RED HIVE LIKE BLOTCH AT INJECTION SITE ABOUT 2-3 INCHES SPLOTCH.